Evidence map›Paper›PMID 36926298›Full record

ArticleRSC advances2023

Magnetized chitosan hydrogel and silk fibroin, reinforced with PVA: a novel nanobiocomposite for biomedical and hyperthermia applications.

Reza Eivazzadeh-Keihan, Zeinab Pajoum, Hooman Aghamirza Moghim Aliabadi, Adibeh Mohammadi, Amir Kashtiaray, Milad Salimi Bani, Banafshe Pishva, Ali Maleki, Majid M Heravi, Mohammad Mahdavi and 1 more

Erratum issuedOpen access · goldFull text read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Magnetic Hydrogels as a Treatment for Oncological Pathologies.Journal of functional biomaterials · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Reza Eivazzadeh-KeihanCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran maleki@iust.ac.ir +98-21-73021584 +98-21-73228313.
Zeinab PajoumDepartment of Chemistry, School of Physics and Chemistry, Alzahra University PO Box 1993891176, Vanak Tehran Iran mmheravi@alzahra.ac.ir.
Hooman Aghamirza Moghim AliabadiAdvanced Chemical Studies Lab, Department of Chemistry, K. N. Toosi University of Technology Tehran Iran.ORCID https://orcid.org/0000-0003-2150-5721
Adibeh MohammadiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran maleki@iust.ac.ir +98-21-73021584 +98-21-73228313.
Amir KashtiarayCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran maleki@iust.ac.ir +98-21-73021584 +98-21-73228313.
Milad Salimi BaniDepartment of Biomedical Engineering, Faculty of Engineering, University of Isfahan Isfahan Iran.
Banafshe PishvaCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran maleki@iust.ac.ir +98-21-73021584 +98-21-73228313.ORCID https://orcid.org/0000-0002-8079-4706
Ali MalekiCatalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology Tehran 16846-13114 Iran maleki@iust.ac.ir +98-21-73021584 +98-21-73228313.ORCID https://orcid.org/0000-0001-5490-3350
Majid M HeraviDepartment of Chemistry, School of Physics and Chemistry, Alzahra University PO Box 1993891176, Vanak Tehran Iran mmheravi@alzahra.ac.ir.
Mohammad MahdaviEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@sina.tums.ac.ir.ORCID https://orcid.org/0000-0002-8007-2543
Elaheh Ziaei ZiabariDepartment of Orthopedic Surgery, Rothman Institute, Thomas Jefferson University 125 South 9th Street, Suite 1000 Philadelphia PA 19107 USA.
Iran University of Science and Technology · IRAlzahra University · IRK.N.Toosi University of Technology · IRTehran University of Medical Sciences · IRThomas Jefferson University · USUniversity of Isfahan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, a multifunctional nanobiocomposite was designed for biological application, amongst which hyperthermia cancer therapy application was specifically investigated. This nanobiocomposite was fabricated based on chitosan hydrogel (CS), silk fibroin (SF), water-soluble polymer polyvinyl alcohol (PVA) and iron oxide magnetic nanoparticles (Fe

Identifiers

PMID36926298
PMCPMC10012334
OpenAlexW4324281704

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read78
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.